|
|
|
|
LEADER |
02000 am a22002293u 4500 |
001 |
134465 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Gref, R
|e author
|
700 |
1 |
0 |
|a Domb, A
|e author
|
700 |
1 |
0 |
|a Quellec, P
|e author
|
700 |
1 |
0 |
|a Blunk, T
|e author
|
700 |
1 |
0 |
|a Müller, RH
|e author
|
700 |
1 |
0 |
|a Verbavatz, JM
|e author
|
700 |
1 |
0 |
|a Langer, R
|e author
|
245 |
0 |
0 |
|a The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
|
260 |
|
|
|b Elsevier BV,
|c 2021-10-27T20:05:07Z.
|
856 |
|
|
|z Get fulltext
|u https://hdl.handle.net/1721.1/134465
|
520 |
|
|
|a Injectable blood persistent particulate carriers have important therapeutic application in site-specific drug delivery or medical imaging. However, injected particles are generally eliminated by the reticulo-endothelial system within minutes after administration and accumulate in the liver and spleen. To obtain a coating that might prevent opsonization and subsequent recognition by the macrophages, sterically stabilized nanospheres were developed using amphiphilic diblock or multiblock copolymers. The nanospheres are composed of a hydrophilic polyethylene glycol coating and a biodegradable core in which various drugs were encapsulated. Hydrophobic drugs, such as lidocaine, were entrapped up to 45. wt% and the release kinetics were governed by the polymer physico-chemical characteristics. Plasma protein adsorption was drastically reduced on PEG-coated particles compared to non-coated ones. Relative protein amounts were time-dependent. The nanospheres exhibited increased blood circulation times and reduced liver accumulation, depending on the coating polyethylene glycol molecular weight and surface density. They could be freeze-dried and redispersed in aqueous solutions and possess good shelf stability. It may be possible to tailor "optimal" polymers for given therapeutic applications. © 2012.
|
546 |
|
|
|a en
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t 10.1016/j.addr.2012.09.008
|
773 |
|
|
|t Advanced Drug Delivery Reviews
|